| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/26/2023 | 23.29% | Roth MKM | $35 → $18 | Downgrades | Buy → Neutral |
| 10/24/2023 | 105.48% | Susquehanna | $40 → $30 | Maintains | Positive |
| 10/19/2023 | 126.03% | Stifel | $38 → $33 | Maintains | Buy |
| 10/19/2023 | 57.53% | Deutsche Bank | → $23 | Downgrades | Buy → Hold |
| 08/01/2023 | 71.23% | Loop Capital | → $25 | Downgrades | Buy → Hold |
| 07/27/2023 | 139.73% | Benchmark | → $35 | Reiterates | Buy → Buy |
| 07/27/2023 | 71.23% | Craig-Hallum | → $25 | Downgrades | Buy → Hold |
| 07/27/2023 | 132.88% | Needham | → $34 | Reiterates | Buy → Buy |
| 05/19/2023 | 105.48% | Exane BNP Paribas | → $30 | Upgrades | Underperform → Neutral |
| 04/27/2023 | 173.97% | Roth Capital | $50 → $40 | Maintains | Buy |
| 04/27/2023 | 71.23% | Northland Capital Markets | $35 → $25 | Maintains | Market Perform |
| 04/27/2023 | 153.42% | Craig-Hallum | $55 → $37 | Maintains | Action List Buy |
| 04/27/2023 | 173.97% | Roth MKM | $50 → $40 | Maintains | Buy |
| 04/27/2023 | 187.67% | Stifel | $48 → $42 | Maintains | Buy |
| 04/27/2023 | 132.88% | Needham | $48 → $34 | Maintains | Buy |
| 04/25/2023 | 208.22% | Susquehanna | $48 → $45 | Maintains | Positive |
| 04/19/2023 | 228.77% | Stifel | $50 → $48 | Maintains | Buy |
| 03/09/2023 | 228.77% | Susquehanna | → $48 | Reiterates | → Positive |
| 02/03/2023 | 221.92% | Benchmark | $50 → $47 | Maintains | Buy |
| 02/02/2023 | 228.77% | Susquehanna | $46 → $48 | Maintains | Positive |
| 02/02/2023 | 228.77% | Needham | $50 → $48 | Maintains | Buy |
| 10/26/2022 | 242.47% | Needham | $53 → $50 | Maintains | Buy |
| 07/20/2022 | 208.22% | Deutsche Bank | $55 → $45 | Maintains | Buy |
| 07/11/2022 | 242.47% | Wells Fargo | $66 → $50 | Maintains | Overweight |
| 05/09/2022 | 310.96% | Susquehanna | → $60 | Upgrades | Neutral → Positive |
| 04/28/2022 | 352.05% | Wells Fargo | → $66 | Upgrades | Equal-Weight → Overweight |
| 04/28/2022 | 345.21% | Needham | $80 → $65 | Maintains | Buy |
| 04/20/2022 | 276.71% | Deutsche Bank | $65 → $55 | Maintains | Hold |
| 02/03/2022 | 447.95% | Needham | $67 → $80 | Maintains | Buy |
| 12/21/2021 | 379.45% | Wells Fargo | $55 → $70 | Maintains | Equal-Weight |
| 10/28/2021 | 358.9% | Needham | $54 → $67 | Maintains | Buy |
| 09/02/2021 | 379.45% | Roth Capital | $50 → $70 | Maintains | Buy |
| 07/29/2021 | 269.86% | Needham | $50 → $54 | Maintains | Buy |
| 07/29/2021 | 208.22% | Wells Fargo | $35 → $45 | Maintains | Equal-Weight |
| 04/29/2021 | 242.47% | Needham | $45 → $50 | Maintains | Buy |
| 02/08/2021 | 194.52% | Loop Capital | → $43 | Upgrades | Hold → Buy |
| 01/11/2021 | — | Wells Fargo | Downgrades | Overweight → Equal-Weight | |
| 01/04/2021 | 242.47% | Roth Capital | $40 → $50 | Maintains | Buy |
| 11/06/2020 | 173.97% | Roth Capital | $35 → $40 | Maintains | Buy |
| 11/06/2020 | 173.97% | Needham | $37 → $40 | Maintains | Buy |
| 07/24/2020 | 119.18% | Stifel | $29 → $32 | Maintains | Buy |
| 07/24/2020 | 105.48% | Roth Capital | → $30 | Upgrades | Neutral → Buy |
| 07/23/2020 | 84.93% | Loop Capital | → $27 | Initiates Coverage On | → Hold |
| 07/17/2020 | 64.38% | Deutsche Bank | $20 → $24 | Maintains | Hold |
| 07/07/2020 | 126.03% | Needham | $23 → $33 | Maintains | Buy |
| 05/04/2020 | 50.68% | Craig-Hallum | → $22 | Initiates Coverage On | → Buy |
| 04/30/2020 | 36.99% | Susquehanna | $15 → $20 | Maintains | Neutral |
| 04/30/2020 | 50.68% | Stifel | $19 → $22 | Maintains | Buy |
| 04/07/2020 | 36.99% | Northland Capital Markets | $25 → $20 | Maintains | Outperform |
| 04/07/2020 | 57.53% | Wells Fargo | $21 → $23 | Upgrades | Equal-Weight → Overweight |
| 02/06/2020 | 57.53% | Needham | $24 → $23 | Maintains | Buy |
| 12/16/2019 | 71.23% | Northland Capital Markets | → $25 | Initiates Coverage On | → Outperform |
| 11/19/2019 | — | Needham | Upgrades | Hold → Buy | |
| 05/15/2019 | — | Wells Fargo | Initiates Coverage On | → Market Perform | |
| 05/02/2019 | — | Needham | Downgrades | Buy → Hold | |
| 01/04/2019 | 23.29% | JP Morgan | → $18 | Initiates Coverage On | → Neutral |
What is the target price for MaxLinear (MXL)?
The latest price target for MaxLinear (NASDAQ: MXL) was reported by Roth MKM on October 26, 2023. The analyst firm set a price target for $18.00 expecting MXL to rise to within 12 months (a possible 23.29% upside). 21 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for MaxLinear (MXL)?
The latest analyst rating for MaxLinear (NASDAQ: MXL) was provided by Roth MKM, and MaxLinear downgraded their neutral rating.
When is the next analyst rating going to be posted or updated for MaxLinear (MXL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MaxLinear, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MaxLinear was filed on October 26, 2023 so you should expect the next rating to be made available sometime around October 26, 2024.
Is the Analyst Rating MaxLinear (MXL) correct?
While ratings are subjective and will change, the latest MaxLinear (MXL) rating was a downgraded with a price target of $35.00 to $18.00. The current price MaxLinear (MXL) is trading at is $14.60, which is out of the analyst's predicted range.